COVID-19 in Colombia endpoints. Are we different, like Europe?

ABSTRACT: The infection by the new coronavirus (SARS-CoV-2) has taken the dimension of a pandemic, affecting more than 160 countries in a few weeks. In Colombia, despite the implementation of the rules established by the national government, exists an elevate concern both for mortality and for the l...

Full description

Autores:
Amariles Muñoz, Pedro
Ceballos Rueda, Javier Mauricio
Granados Vega, Elkyn Johan
Montoya Guarín, Carlos Julio
Tipo de recurso:
Article of investigation
Fecha de publicación:
2021
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/38832
Acceso en línea:
https://hdl.handle.net/10495/38832
Palabra clave:
COVID-19
Colombia - epidemiología
Colombia - epidemiology
Atención a la Salud - organización & administración
Delivery of Health Care - organization & administration
Europa (Continente) - epidemiología
Europe - epidemiology
Humanos
Humans
Factores de Riesgo
Risk Factors
https://id.nlm.nih.gov/mesh/D000086382
https://id.nlm.nih.gov/mesh/D003105
https://id.nlm.nih.gov/mesh/D003695
https://id.nlm.nih.gov/mesh/D005060
https://id.nlm.nih.gov/mesh/D006801
https://id.nlm.nih.gov/mesh/D012307
Rights
openAccess
License
https://creativecommons.org/licenses/by-nc-nd/4.0/
id UDEA2_62aff1a79447a25b81da895436bbad98
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/38832
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv COVID-19 in Colombia endpoints. Are we different, like Europe?
title COVID-19 in Colombia endpoints. Are we different, like Europe?
spellingShingle COVID-19 in Colombia endpoints. Are we different, like Europe?
COVID-19
Colombia - epidemiología
Colombia - epidemiology
Atención a la Salud - organización & administración
Delivery of Health Care - organization & administration
Europa (Continente) - epidemiología
Europe - epidemiology
Humanos
Humans
Factores de Riesgo
Risk Factors
https://id.nlm.nih.gov/mesh/D000086382
https://id.nlm.nih.gov/mesh/D003105
https://id.nlm.nih.gov/mesh/D003695
https://id.nlm.nih.gov/mesh/D005060
https://id.nlm.nih.gov/mesh/D006801
https://id.nlm.nih.gov/mesh/D012307
title_short COVID-19 in Colombia endpoints. Are we different, like Europe?
title_full COVID-19 in Colombia endpoints. Are we different, like Europe?
title_fullStr COVID-19 in Colombia endpoints. Are we different, like Europe?
title_full_unstemmed COVID-19 in Colombia endpoints. Are we different, like Europe?
title_sort COVID-19 in Colombia endpoints. Are we different, like Europe?
dc.creator.fl_str_mv Amariles Muñoz, Pedro
Ceballos Rueda, Javier Mauricio
Granados Vega, Elkyn Johan
Montoya Guarín, Carlos Julio
dc.contributor.author.none.fl_str_mv Amariles Muñoz, Pedro
Ceballos Rueda, Javier Mauricio
Granados Vega, Elkyn Johan
Montoya Guarín, Carlos Julio
dc.contributor.researchgroup.spa.fl_str_mv Grupo de Investigación de Tecnología en Regencia de Farmacia
Promoción y Prevención Farmacéutica
dc.subject.decs.none.fl_str_mv COVID-19
Colombia - epidemiología
Colombia - epidemiology
Atención a la Salud - organización & administración
Delivery of Health Care - organization & administration
Europa (Continente) - epidemiología
Europe - epidemiology
Humanos
Humans
Factores de Riesgo
Risk Factors
topic COVID-19
Colombia - epidemiología
Colombia - epidemiology
Atención a la Salud - organización & administración
Delivery of Health Care - organization & administration
Europa (Continente) - epidemiología
Europe - epidemiology
Humanos
Humans
Factores de Riesgo
Risk Factors
https://id.nlm.nih.gov/mesh/D000086382
https://id.nlm.nih.gov/mesh/D003105
https://id.nlm.nih.gov/mesh/D003695
https://id.nlm.nih.gov/mesh/D005060
https://id.nlm.nih.gov/mesh/D006801
https://id.nlm.nih.gov/mesh/D012307
dc.subject.meshuri.none.fl_str_mv https://id.nlm.nih.gov/mesh/D000086382
https://id.nlm.nih.gov/mesh/D003105
https://id.nlm.nih.gov/mesh/D003695
https://id.nlm.nih.gov/mesh/D005060
https://id.nlm.nih.gov/mesh/D006801
https://id.nlm.nih.gov/mesh/D012307
description ABSTRACT: The infection by the new coronavirus (SARS-CoV-2) has taken the dimension of a pandemic, affecting more than 160 countries in a few weeks. In Colombia, despite the implementation of the rules established by the national government, exists an elevate concern both for mortality and for the limited capacity of the health system to respond effectively to the needs of patients infected. For Colombia, assuming a case fatality rate among people infected with SARS-CoV-2 of 0.6% (average data from the information reported for Latin American countries for March 18) (Table 1), the number of deaths, in one or two weeks, could be 16 and 243, respectively. These estimates differ markedly from those documented in countries such as Spain and Italy, in which COVID-19 case fatality rates exceed 8% (case of Italy) and from the percentage of patients who have required intensive care, which has ranged from 9% to 11% of patients in Mediterranean European countries. These differences could be explained due to: a) the percentage of the population at risk (individuals older than 60 years); b) a higher epidemiological exposure to viral respiratory infections associated with more frequent exposure to them, due to geographic and climatic conditions; c) less spread of the virus by location in the tropical zone; and d) earlier preventive measures to contain the spread of SARS-CoV-2 infection. Therefore, it is possible to establish that the situation in this country will be different from in European Mediterranean and that Colombia could have different endpoints from Spain and Italy.
publishDate 2021
dc.date.issued.none.fl_str_mv 2021
dc.date.accessioned.none.fl_str_mv 2024-03-27T20:31:19Z
dc.date.available.none.fl_str_mv 2024-03-27T20:31:19Z
dc.type.spa.fl_str_mv Artículo de investigación
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.citation.spa.fl_str_mv Amariles P, Granados J, Ceballos M, Montoya CJ. COVID-19 in Colombia endpoints. Are we different, like Europe? Res Social Adm Pharm. 2021 Jan;17(1):2036-2039. doi: 10.1016/j.sapharm.2020.03.013.
dc.identifier.issn.none.fl_str_mv 1551-7411
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/10495/38832
dc.identifier.doi.none.fl_str_mv 10.1016/j.sapharm.2020.03.013
dc.identifier.eissn.none.fl_str_mv 1934-8150
identifier_str_mv Amariles P, Granados J, Ceballos M, Montoya CJ. COVID-19 in Colombia endpoints. Are we different, like Europe? Res Social Adm Pharm. 2021 Jan;17(1):2036-2039. doi: 10.1016/j.sapharm.2020.03.013.
1551-7411
10.1016/j.sapharm.2020.03.013
1934-8150
url https://hdl.handle.net/10495/38832
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv Res. Social Adm. Pharm.
dc.relation.citationendpage.spa.fl_str_mv 2039
dc.relation.citationissue.spa.fl_str_mv 1
dc.relation.citationstartpage.spa.fl_str_mv 2036
dc.relation.citationvolume.spa.fl_str_mv 17
dc.relation.ispartofjournal.spa.fl_str_mv Research in Social and Administrative Pharmacy
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.extent.spa.fl_str_mv 4 páginas
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Elsevier
dc.publisher.place.spa.fl_str_mv Nueva York, Estados Unidos
institution Universidad de Antioquia
bitstream.url.fl_str_mv https://bibliotecadigital.udea.edu.co/bitstreams/8fb4ad41-83af-4e56-8423-d0d24f69fd57/download
https://bibliotecadigital.udea.edu.co/bitstreams/c331e006-8faa-4f4a-be8e-1538c6d0365e/download
https://bibliotecadigital.udea.edu.co/bitstreams/b01f63bb-b3e7-4353-b064-ddfa275d30e4/download
https://bibliotecadigital.udea.edu.co/bitstreams/d40cbde0-00bd-497f-8e07-87daa3d1c4fe/download
https://bibliotecadigital.udea.edu.co/bitstreams/d87b7f83-cd82-46d9-8d83-8534d26e511f/download
bitstream.checksum.fl_str_mv c14532da293bbe707483482c1f026825
b88b088d9957e670ce3b3fbe2eedbc13
8a4605be74aa9ea9d79846c1fba20a33
e8df02e7e8573f3506f231e0951fd2b8
527d6262d67ae58b1c685d17ae914768
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional de la Universidad de Antioquia
repository.mail.fl_str_mv aplicacionbibliotecadigitalbiblioteca@udea.edu.co
_version_ 1851052249062572032
spelling Amariles Muñoz, PedroCeballos Rueda, Javier MauricioGranados Vega, Elkyn JohanMontoya Guarín, Carlos JulioGrupo de Investigación de Tecnología en Regencia de FarmaciaPromoción y Prevención Farmacéutica2024-03-27T20:31:19Z2024-03-27T20:31:19Z2021Amariles P, Granados J, Ceballos M, Montoya CJ. COVID-19 in Colombia endpoints. Are we different, like Europe? Res Social Adm Pharm. 2021 Jan;17(1):2036-2039. doi: 10.1016/j.sapharm.2020.03.013.1551-7411https://hdl.handle.net/10495/3883210.1016/j.sapharm.2020.03.0131934-8150ABSTRACT: The infection by the new coronavirus (SARS-CoV-2) has taken the dimension of a pandemic, affecting more than 160 countries in a few weeks. In Colombia, despite the implementation of the rules established by the national government, exists an elevate concern both for mortality and for the limited capacity of the health system to respond effectively to the needs of patients infected. For Colombia, assuming a case fatality rate among people infected with SARS-CoV-2 of 0.6% (average data from the information reported for Latin American countries for March 18) (Table 1), the number of deaths, in one or two weeks, could be 16 and 243, respectively. These estimates differ markedly from those documented in countries such as Spain and Italy, in which COVID-19 case fatality rates exceed 8% (case of Italy) and from the percentage of patients who have required intensive care, which has ranged from 9% to 11% of patients in Mediterranean European countries. These differences could be explained due to: a) the percentage of the population at risk (individuals older than 60 years); b) a higher epidemiological exposure to viral respiratory infections associated with more frequent exposure to them, due to geographic and climatic conditions; c) less spread of the virus by location in the tropical zone; and d) earlier preventive measures to contain the spread of SARS-CoV-2 infection. Therefore, it is possible to establish that the situation in this country will be different from in European Mediterranean and that Colombia could have different endpoints from Spain and Italy.COL0135121COL00746614 páginasapplication/pdfengElsevierNueva York, Estados Unidoshttps://creativecommons.org/licenses/by-nc-nd/4.0/http://creativecommons.org/licenses/by-nc-nd/2.5/co/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2COVID-19 in Colombia endpoints. Are we different, like Europe?Artículo de investigaciónhttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionCOVID-19Colombia - epidemiologíaColombia - epidemiologyAtención a la Salud - organización & administraciónDelivery of Health Care - organization & administrationEuropa (Continente) - epidemiologíaEurope - epidemiologyHumanosHumansFactores de RiesgoRisk Factorshttps://id.nlm.nih.gov/mesh/D000086382https://id.nlm.nih.gov/mesh/D003105https://id.nlm.nih.gov/mesh/D003695https://id.nlm.nih.gov/mesh/D005060https://id.nlm.nih.gov/mesh/D006801https://id.nlm.nih.gov/mesh/D012307Res. Social Adm. Pharm.20391203617Research in Social and Administrative PharmacyPublicationORIGINALAmarilesPedro_2021_COVID-19_Colombia_Endpoints.pdfAmarilesPedro_2021_COVID-19_Colombia_Endpoints.pdfArtículo de investigaciónapplication/pdf1929292https://bibliotecadigital.udea.edu.co/bitstreams/8fb4ad41-83af-4e56-8423-d0d24f69fd57/downloadc14532da293bbe707483482c1f026825MD51trueAnonymousREADCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8823https://bibliotecadigital.udea.edu.co/bitstreams/c331e006-8faa-4f4a-be8e-1538c6d0365e/downloadb88b088d9957e670ce3b3fbe2eedbc13MD52falseAnonymousREADLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstreams/b01f63bb-b3e7-4353-b064-ddfa275d30e4/download8a4605be74aa9ea9d79846c1fba20a33MD53falseAnonymousREADTEXTAmarilesPedro_2021_COVID-19_Colombia_Endpoints.pdf.txtAmarilesPedro_2021_COVID-19_Colombia_Endpoints.pdf.txtExtracted texttext/plain20238https://bibliotecadigital.udea.edu.co/bitstreams/d40cbde0-00bd-497f-8e07-87daa3d1c4fe/downloade8df02e7e8573f3506f231e0951fd2b8MD54falseAnonymousREADTHUMBNAILAmarilesPedro_2021_COVID-19_Colombia_Endpoints.pdf.jpgAmarilesPedro_2021_COVID-19_Colombia_Endpoints.pdf.jpgGenerated Thumbnailimage/jpeg16013https://bibliotecadigital.udea.edu.co/bitstreams/d87b7f83-cd82-46d9-8d83-8534d26e511f/download527d6262d67ae58b1c685d17ae914768MD55falseAnonymousREAD10495/38832oai:bibliotecadigital.udea.edu.co:10495/388322025-03-26 19:19:59.822https://creativecommons.org/licenses/by-nc-nd/4.0/open.accesshttps://bibliotecadigital.udea.edu.coRepositorio Institucional de la Universidad de Antioquiaaplicacionbibliotecadigitalbiblioteca@udea.edu.coTk9URTogUExBQ0UgWU9VUiBPV04gTElDRU5TRSBIRVJFClRoaXMgc2FtcGxlIGxpY2Vuc2UgaXMgcHJvdmlkZWQgZm9yIGluZm9ybWF0aW9uYWwgcHVycG9zZXMgb25seS4KCk5PTi1FWENMVVNJVkUgRElTVFJJQlVUSU9OIExJQ0VOU0UKCkJ5IHNpZ25pbmcgYW5kIHN1Ym1pdHRpbmcgdGhpcyBsaWNlbnNlLCB5b3UgKHRoZSBhdXRob3Iocykgb3IgY29weXJpZ2h0Cm93bmVyKSBncmFudHMgdG8gRFNwYWNlIFVuaXZlcnNpdHkgKERTVSkgdGhlIG5vbi1leGNsdXNpdmUgcmlnaHQgdG8gcmVwcm9kdWNlLAp0cmFuc2xhdGUgKGFzIGRlZmluZWQgYmVsb3cpLCBhbmQvb3IgZGlzdHJpYnV0ZSB5b3VyIHN1Ym1pc3Npb24gKGluY2x1ZGluZwp0aGUgYWJzdHJhY3QpIHdvcmxkd2lkZSBpbiBwcmludCBhbmQgZWxlY3Ryb25pYyBmb3JtYXQgYW5kIGluIGFueSBtZWRpdW0sCmluY2x1ZGluZyBidXQgbm90IGxpbWl0ZWQgdG8gYXVkaW8gb3IgdmlkZW8uCgpZb3UgYWdyZWUgdGhhdCBEU1UgbWF5LCB3aXRob3V0IGNoYW5naW5nIHRoZSBjb250ZW50LCB0cmFuc2xhdGUgdGhlCnN1Ym1pc3Npb24gdG8gYW55IG1lZGl1bSBvciBmb3JtYXQgZm9yIHRoZSBwdXJwb3NlIG9mIHByZXNlcnZhdGlvbi4KCllvdSBhbHNvIGFncmVlIHRoYXQgRFNVIG1heSBrZWVwIG1vcmUgdGhhbiBvbmUgY29weSBvZiB0aGlzIHN1Ym1pc3Npb24gZm9yCnB1cnBvc2VzIG9mIHNlY3VyaXR5LCBiYWNrLXVwIGFuZCBwcmVzZXJ2YXRpb24uCgpZb3UgcmVwcmVzZW50IHRoYXQgdGhlIHN1Ym1pc3Npb24gaXMgeW91ciBvcmlnaW5hbCB3b3JrLCBhbmQgdGhhdCB5b3UgaGF2ZQp0aGUgcmlnaHQgdG8gZ3JhbnQgdGhlIHJpZ2h0cyBjb250YWluZWQgaW4gdGhpcyBsaWNlbnNlLiBZb3UgYWxzbyByZXByZXNlbnQKdGhhdCB5b3VyIHN1Ym1pc3Npb24gZG9lcyBub3QsIHRvIHRoZSBiZXN0IG9mIHlvdXIga25vd2xlZGdlLCBpbmZyaW5nZSB1cG9uCmFueW9uZSdzIGNvcHlyaWdodC4KCklmIHRoZSBzdWJtaXNzaW9uIGNvbnRhaW5zIG1hdGVyaWFsIGZvciB3aGljaCB5b3UgZG8gbm90IGhvbGQgY29weXJpZ2h0LAp5b3UgcmVwcmVzZW50IHRoYXQgeW91IGhhdmUgb2J0YWluZWQgdGhlIHVucmVzdHJpY3RlZCBwZXJtaXNzaW9uIG9mIHRoZQpjb3B5cmlnaHQgb3duZXIgdG8gZ3JhbnQgRFNVIHRoZSByaWdodHMgcmVxdWlyZWQgYnkgdGhpcyBsaWNlbnNlLCBhbmQgdGhhdApzdWNoIHRoaXJkLXBhcnR5IG93bmVkIG1hdGVyaWFsIGlzIGNsZWFybHkgaWRlbnRpZmllZCBhbmQgYWNrbm93bGVkZ2VkCndpdGhpbiB0aGUgdGV4dCBvciBjb250ZW50IG9mIHRoZSBzdWJtaXNzaW9uLgoKSUYgVEhFIFNVQk1JU1NJT04gSVMgQkFTRUQgVVBPTiBXT1JLIFRIQVQgSEFTIEJFRU4gU1BPTlNPUkVEIE9SIFNVUFBPUlRFRApCWSBBTiBBR0VOQ1kgT1IgT1JHQU5JWkFUSU9OIE9USEVSIFRIQU4gRFNVLCBZT1UgUkVQUkVTRU5UIFRIQVQgWU9VIEhBVkUKRlVMRklMTEVEIEFOWSBSSUdIVCBPRiBSRVZJRVcgT1IgT1RIRVIgT0JMSUdBVElPTlMgUkVRVUlSRUQgQlkgU1VDSApDT05UUkFDVCBPUiBBR1JFRU1FTlQuCgpEU1Ugd2lsbCBjbGVhcmx5IGlkZW50aWZ5IHlvdXIgbmFtZShzKSBhcyB0aGUgYXV0aG9yKHMpIG9yIG93bmVyKHMpIG9mIHRoZQpzdWJtaXNzaW9uLCBhbmQgd2lsbCBub3QgbWFrZSBhbnkgYWx0ZXJhdGlvbiwgb3RoZXIgdGhhbiBhcyBhbGxvd2VkIGJ5IHRoaXMKbGljZW5zZSwgdG8geW91ciBzdWJtaXNzaW9uLgo=